Catalyst Pharmaceuticals (CPRX) Shares Outstanding (Diluted Average) (2018 - 2024)

Catalyst Pharmaceuticals has reported Shares Outstanding (Diluted Average) for 7 years, with the latest figure at $123.4 million in Q1 2024.

• For the quarter ending Q1 2024, Shares Outstanding (Diluted Average) rose 8.26% year-over-year to $123.4 million; the trailing twelve-month figure through Mar 2024 stood at $123.4 million (up 8.26% YoY), and the FY2023 full-year result was $113.8 million, up 2.13% from the prior year.
• Shares Outstanding (Diluted Average) for Q1 2024 stood at $123.4 million, up from $113.8 million in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $123.4 million in Q1 2024, with the low at $106.2 million in Q4 2020.
• Historically, Shares Outstanding (Diluted Average) has averaged $109.9 million across 5 years, with a median of $107.8 million in 2021.
• Annual changes were most pronounced in 2023 — Shares Outstanding (Diluted Average) dropped 4.84% — and 2024, when it rose 8.26%.
• Catalyst Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $106.2 million in 2020, then advanced by 1.46% to $107.8 million in 2021, then advanced by 3.32% to $111.4 million in 2022, then gained by 2.13% to $113.8 million in 2023, then advanced by 8.48% to $123.4 million in 2024.
• The last three Shares Outstanding (Diluted Average) figures came in at $123.4 million (Q1 2024), $113.8 million (Q4 2023), and $106.6 million (Q3 2023), per Business Quant data.